The European Commission has approved the combination of Tecentriq (atezolizumab) plus chemotherapy (Abraxane) for the treatment of patients with locally unresectable or metastatic advanced breast … Read more
Bone cancer is one of the less frequent neoplasms, but just as deadly as the rest of the malignant tumors. According to data from the … Read more
Being obese has overtaken smoking as the main cause of four common types of cancer. Cancer Research UK (CRUK), a research and outreach foundation in … Read more
An international collaboration, using data from more than 100,000 women with breast cancer from 58 epidemiological studies worldwide, has found that the use of menopausal … Read more
New York.– A retired detective from the New York Police of Cuban origin died this Saturday for a Cancer related to the substances that he … Read more
New data from a real-life study show that afatinib followed by osimertinib provided a median overall survival of up to almost four years (45.7 months) … Read more
Nanopharmacia Group and FUCAM (Breast Cancer Foundation) -institution that attends more cases at national level and national leader in Mexico and Latin America-, signed an … Read more
Cancer already kills twice as many people as cardiovascular diseases in rich countries, although globally it is the cardiac pathologies that cause the most deaths, … Read more
The researcher of the La Trobe University, in Australia, and associate professor Hamsa Puthalakath is the first scientist to discover why some cancers do not … Read more
September 5 is World Multiple Myeloma Day, the second most frequent hematological tumor in adults, difficult to diagnose and although it still has no cure, … Read more